Tendersinfo Gulf

Filter Search

Healthcare and Medical

Location Summary Deadline
Germany Completion Not Excl. Pharmaceutical Discount Club. According To § 130a Para. 8 Sgb V In The Way Of An Open House Model To The Active Ingredient Ustekinumab (atccode According To Who 2025-11-19
Germany Open-house-drug Discount Contracts In Accordance With Section 130a (8c) Sgb V For The Kv-region Berlin 2025-11-19
Germany Open House Pharmaceutical Dact Treaties To The Active Ingredient Leuprorelin, Atc L02ae02, H01ca04 2025-11-19
Germany Completion Of A Non -excessive Discount Agreement According To § 130a Para. 8 Sgb V For The Active Ingredient Lenalidomide, Atc L04ax04 For The Time 01.07.2025 30.06.2027 (plus Extension Option 1x12 Months), Medicines 2025-11-19
Germany Completion Of A Non -excessive Discount Agreement According To § 130a Para. 8 Sgb V For The Active Ingredient Glatirameracetate (exclusively Dosage Form), Atc L03ax13 For The Time 01.07.25 30.06.27, Medicines 2025-11-19
United States I-corps Program At The National Cancer Institute. 2025-11-20
Norway Price Agreement Oslo, Akershus - Oslo Airport 2025-11-20
Germany Conclusion Of Non-exclusive Discount Agreements Pursuant To Section 130a Paragraph 8 Of The Social Code Book V For The Active Substances Mentioned With The Possibility Of Conclusion Within The Framework Of The So-called Open House Procedure. 2025-11-20
United States Bovine Spongiform Encephalopathy (bse) Surveillance Sample Collection 2025-11-20
United States Bovine Spongiform Encephalopathy (bse) Surveillance Sample Collection 2025-11-20
Whats app